[ Price : $8.95]
Boehringer Ingelheim discontinues a Phase 2 trial of a first-in-class compound for reducing the risk or severity of acute respirat...[ Price : $8.95]
FDA acting commissioner Janet Woodcock discusses two lessons learned about clinical research from the Covid-19 pandemic.[ Price : $8.95]
FDA extends the PDUFA review date for Kadmons belumosudil for three months to review additional information submitted by the compa...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension entitled Prescription Drug Marketing 21 CFR Pa...[ Price : $8.95]
Federal Register notice: FDA issues a priority review voucher to Origin Biosciences after it gained approval for a qualified rare ...[ Price : $8.95]
FDA approves an Aveo Oncology NDA for Fotivda (tivozanib) for treating adults with relapsed or refractory advanced renal cell carc...[ Price : $8.95]
FDA announces a three-day Oncologic Drugs Advisory Committee meeting to discuss the continued approval of six indications associat...[ Price : $8.95]
FDA releases revisions to four sections of labeling for ViiVs Triumeq and Dovato.